Symbol="AYTU"
AssetType="Common Stock"
Name="Aytu BioScience Inc"
Description="Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and marketing novel products in the field of hypogonadism (low testosterone levels), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company is headquartered in Englewood, Colorado."
CIK="1385818"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="16200 WCR 18E, LOVELAND, CO, US"
FiscalYearEnd="June"
LatestQuarter="2023-03-31"
MarketCapitalization="10328900"
EBITDA="-13218000"
PERatio="None"
PEGRatio="0"
BookValue="10.82"
DividendPerShare="0"
DividendYield="0"
EPS="-11.94"
RevenuePerShareTTM="37.53"
ProfitMargin="-0.308"
OperatingMarginTTM="-0.214"
ReturnOnAssetsTTM="-0.088"
ReturnOnEquityTTM="-0.629"
RevenueTTM="104115000"
GrossProfitTTM="52283000"
DilutedEPSTTM="-11.94"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.061"
AnalystTargetPrice="120"
TrailingPE="-"
ForwardPE="10.7"
PriceToSalesRatioTTM="0.13"
PriceToBookRatio="0.243"
EVToRevenue="0.116"
EVToEBITDA="-0.605"
Beta="-0.43"
num_52WeekHigh="13.13"
num_52WeekLow="1.38"
num_50DayMovingAverage="1.747"
num_200DayMovingAverage="2.861"
SharesOutstanding="5523500"
DividendDate="2020-12-09"
ExDividendDate="None"
symbol="AYTU"
open="1.86"
high="1.88"
low="1.82"
price="1.87"
volume="21870.00"
latest_trading_day="2023-07-14"
previous_close="1.86"
change="0.01"
change_percent="0.5376%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="74941"
Change_recent_avg="-0.02"
Delta_recent_avg="0.15"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-0.97"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1117"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0150.jpeg"
image_negative_thumbnail_id_2="508"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0097.jpeg"
image_neutral_thumbnail_id_1="555"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_neutral_thumbnail_id_2="573"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_positive_thumbnail_id_1="646"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0062.jpeg"
image_positive_thumbnail_id_2="649"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0059.jpeg"
image_professor_thumbnail_id_1="1201"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
